Please use this identifier to cite or link to this item: https://swslhd.intersearch.com.au/swslhdjspui/handle/1/13152
Title: Medicine Access Programmes: what do patients think ? a patient-reported outcome study on ribociclib in metastatic breast cancer in Australia
Author: Yap, N.
Wong, V.
Morton, C.
de Boer, R.
Baron-Hay, S.
Blum, R.
Forster, B.
Chua, S.
Clarke, K.
Cuff, K.
Green, M.
Lim, E.
Mok, K.
Nott, L.
Nottage, M.
Tafreshi, A.
Tsoi, D.
Uccellini, A.
Gibbs, P.
Lok, S. W.
Issue Date: 2024
Journal: Internal Medicine Journal
Abstract:  This study evaluated patient-reported outcomes (PROs) of Medicine Access Programmes (MAPs) for Australian metastatic breast cancer patients on ribociclib. Limited patient awareness of MAP enrolment was identified, emphasising the need for improved education and consent processes. Most patients expressed gratitude for accessing non-funded medications and perceived enhanced medication adherence as a key benefit. Integrating PRO data with real-world registry data provides comprehensive insight for future MAP development. � 2024 Royal Australasian College of Physicians.
ISSN: 14440903 (ISSN)
Digital object identifier: 10.1111/imj.16536
URI: https://swslhd.intersearch.com.au/swslhdjspui/handle/1/13152
Appears in Collections:Liverpool Hospital

Files in This Item:
There are no files associated with this item.


Items in Prosentient are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing